# Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions

> **NCT01107353** · NA · COMPLETED · sponsor: **Roxane Laboratories** · enrollment: 39 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Imipramine Pamoate

## Key facts

- **NCT ID:** NCT01107353
- **Lead sponsor:** Roxane Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01107353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01107353, "Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01107353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*